Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -21.94% is 56% above its 5-year average of -50.30%, near the high end of its 5-year range (-371.60%–39.52%).
28.66% above its 12-month average of -30.75%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -4.37%.
OPERATING MARGIN
-21.94%
OPERATING MARGIN AVG TTM
-30.75%
OPERATING MARGIN AVG 3Y
-48.84%
OPERATING MARGIN AVG 5Y
-50.30%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+28.66%
CURRENT VS 3Y AVG
+55.07%
CURRENT VS 5Y AVG
+56.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Biofrontera Inc.
Market Cap
$11.41M
Operating Margin
-21.94%
TTM Avg
-30.75%
3Y Avg
-48.84%
5Y Avg
-50.30%
Market Cap
$11.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.21M
Operating Margin
0.00%
TTM Avg
14.10%
3Y Avg
7.05%
5Y Avg
-9488.72%
Market Cap
$11.01M
Operating Margin
-5652.38%
TTM Avg
-2826.19%
3Y Avg
-9617.03%
5Y Avg
-6411.35%
Market Cap
$11.94M
Operating Margin
-5.39%
TTM Avg
-4.88%
3Y Avg
-13.74%
5Y Avg
-13.69%
Market Cap
$11.95M
Operating Margin
N/A
TTM Avg
-2960.13%
3Y Avg
-1713.73%
5Y Avg
-1142.49%
Market Cap
$10.74M
Operating Margin
-293.46%
TTM Avg
-272.89%
3Y Avg
-2404.23%
5Y Avg
-2129.99%
Market Cap
$12.46M
Operating Margin
-33.37%
TTM Avg
-42.32%
3Y Avg
-69.57%
5Y Avg
-60.22%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biofrontera Inc. (BFRI) | $11.41M | -21.94% | -30.75% | -48.84% | -50.30% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | 0.00% | 14.10% | 7.05% | -9488.72% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | -5652.38% | -2826.19% | -9617.03% | -6411.35% |
| IRIDEX Corporation (IRIX)vs › | $11.94M | -5.39% | -4.88% | -13.74% | -13.69% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | N/A | -2960.13% | -1713.73% | -1142.49% |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -293.46% | -272.89% | -2404.23% | -2129.99% |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | -33.37% | -42.32% | -69.57% | -60.22% |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -140807.24% | -140807.24% | -140807.24% | -140807.24% |
Gross Margin
84.5%
Operating Margin
-21.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -4.37% |
| 2026-03-31 | -42.84% |
| 2025-12-31 | 39.52% |
| 2025-09-30 | -89.84% |
| 2025-06-30 | -56.25% |
| 2025-03-31 | -52.95% |
| 2024-12-31 | -13.63% |
| 2024-09-30 | -55.04% |
| 2024-06-30 | -64.69% |
| 2024-03-31 | -69.19% |
| 2023-12-31 | -36.48% |
| 2023-09-30 | -51.93% |
| 2023-06-30 | -148.75% |
| 2023-03-31 | -62.89% |
| 2022-12-31 | -55.40% |
| 2022-09-30 | -84.20% |
| 2022-06-30 | -139.38% |
| 2022-03-31 | -31.89% |
| 2021-12-31 | -20.51% |
| 2021-09-30 | -371.60% |
| 2021-06-30 | -62.97% |
| 2021-03-31 | -74.37% |
| 2020-12-31 | -2.19% |
| 2020-09-30 | -72.08% |
| 2020-06-30 | -104.45% |
| 2020-03-31 | -81.05% |
